| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.11B | 72.54B | 82.59B | 79.62B | 79.23B | 66.09B |
| Gross Profit | 23.20B | 20.41B | 23.34B | 18.37B | 12.01B | 7.04B |
| EBITDA | 16.81B | 14.59B | 17.60B | 13.53B | 7.41B | -2.62B |
| Net Income | 10.33B | 8.07B | 10.85B | 7.89B | 3.66B | -4.72B |
Balance Sheet | ||||||
| Total Assets | 77.19B | 80.45B | 82.39B | 79.14B | 70.48B | 63.64B |
| Cash, Cash Equivalents and Short-Term Investments | 7.31B | 7.17B | 14.17B | 16.35B | 11.88B | 7.38B |
| Total Debt | 4.90B | 4.75B | 5.08B | 6.00B | 7.22B | 7.69B |
| Total Liabilities | 18.02B | 17.03B | 22.67B | 25.98B | 24.33B | 21.22B |
| Stockholders Equity | 59.14B | 63.39B | 59.68B | 53.11B | 46.09B | 42.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.79B | 2.20B | 7.54B | 5.08B | -8.48B |
| Operating Cash Flow | 0.00 | 5.18B | 8.18B | 12.09B | 6.88B | -5.10B |
| Investing Cash Flow | 0.00 | -6.96B | -5.60B | -4.56B | -1.63B | -3.36B |
| Financing Cash Flow | 0.00 | -5.22B | -4.76B | -3.06B | -756.00M | 4.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥46.11B | 6.29 | ― | 6.31% | -12.17% | -23.60% | |
66 Neutral | ¥39.13B | 8.84 | ― | 6.27% | -6.54% | -28.89% | |
65 Neutral | ¥65.48B | 9.27 | ― | 5.15% | -12.34% | -36.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥78.83B | 13.13 | ― | 3.70% | -2.40% | -8.59% | |
55 Neutral | ¥35.35B | 13.50 | ― | 5.02% | -12.42% | -56.79% | |
44 Neutral | ¥67.98B | -1.48 | ― | 1.24% | -18.32% | -943.95% |